Inhibition of Ceramide Synthesis Ameliorates Glucocorticoid-, Saturated-Fat-, and Obesity-Induced Insulin Resistance
University of Utah · Eli Lilly (United States) · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,208
total citations
- FWCI
- 26.64
- Percentile
- 100%
- References
- 54
Citations per year
Authors
15Topics & keywords
Topics
Keywords
- Ceramide
- Sphingolipid
- Insulin resistance
- Internal medicine
- Endocrinology
- Glucocorticoid
- Diabetes mellitus
- Insulin
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.